Sapience Therapeutics Inc.
Changing the tide to achieve the unachievable
HARRISON, United States · Founded 2020 · $4.0M raised
- Headquarters
- HARRISON, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2G
- Website
- sapiencetherapeutics.com
- Total Funding
- $4.0M
- Last Round
- $632K GrantJan 2024
- Rounds
- 5
About
Sapience Therapeutics is a clinical-stage oncology company developing precision peptide therapeutics using its SPEARs™ and SPARCs™ platforms that target intracellular and extracellular protein-protein interactions. Its lead programs, lucicebtide (ST101) and ST316, are in Phase 2 trials for glioblastoma, melanoma, and colorectal cancer.
Summary
Sapience Therapeutics Inc. is a Biotech company based in HARRISON, United States, founded in 2020. It has raised $4.0M in total across 5 rounds, most recently a $632K Grant round in Jan 2024. Investors include National Cancer Institute and National Institute of Allergy and Infectious Diseases.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...